Inhibition of platelet function by administration of MRS2179, a P2Y 1 receptor antagonist

Author： Baurand A. Raboisson P. Freund M. Leon C. Cazenave J.-P. Bourguignon J.-J. Gachet C.

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.412, Iss.3, 2001-02, pp. : 213-221

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Platelet P2Y12 receptor inhibition by thienopyridines: status and future

By Porto Italo Giubilato Simona De Maria Giovanni Luigi Biasucci Luigi Marzio Crea Filippo

Expert Opinion on Investigational Drugs, Vol. 18, Iss. 9, 2009-09 ,pp. : 1317-1332

Informa Healthcare

Access to resources Recommend Favorite

Prasugrel: a novel platelet ADP P2Y₁₂ receptor antagonist. A review on its mechanism of action and clinical development

By Angiolillo Dominick J Suryadevara Siva Capranzano Piera Bass Theodore A

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 16, 2008-11 ,pp. : 2893-2900

Informa Healthcare

Access to resources Recommend Favorite

Platelet P2Y 12 Receptor Inhibition: An Update on Clinical Drug Development

By Vivas David Angiolillo Dominick J.

American Journal of Cardiovascular Drugs, Vol. 10, Iss. 4, 2010-08 ,pp. : 217-226

Adis International

Access to resources Recommend Favorite

P2Y receptor specific for diadenosine tetraphosphate in lung: selective inhibition by suramin, PPADS, Ip 5 I, and not by MRS-2197

By Laubinger W. Wang H. Welte T. Reiser G.

European Journal of Pharmacology, Vol. 468, Iss. 1, 2003-05 ,pp. : 9-14

Elsevier

Access to resources Recommend Favorite

Effects of the neuropeptide Y Y 2 receptor antagonist BIIE0246 on presynaptic inhibition by neuropeptide Y in rat hippocampal slices

By Weiser T. Wieland H.A. Doods H.N.

European Journal of Pharmacology, Vol. 404, Iss. 1, 2000-09 ,pp. : 133-136

Elsevier

Access to resources Recommend Favorite